Have any thoughts about
RadNet Inc?
Write Note

P/E
Price to Earnings

-1 228
Current
65.2
Median
23.1
Industry
Lower than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-1 228
=
Market Cap
5.4B USD
/
Net Income
-4.4m USD
All Countries
Close
Earnings Growth P/E to Growth
US
RadNet Inc
SWB:PQIA
Average P/E: 27
Negative Multiple: -1 228
2 257%
N/A
US
Cigna Corp
NYSE:CI
25.8
96%
0.3
US
C
Cigna Group
XMUN:CGN
25.7
96%
0.3
US
CVS Health Corp
NYSE:CVS
11.3
8%
1.4
DE
Fresenius Medical Care AG
XMUN:FME
48.6
127%
0.4
DE
Fresenius SE & Co KGaA
XETRA:FRE
Negative Multiple: -49.2 N/A N/A
US
Laboratory Corporation of America Holdings
NYSE:LH
44.4
263%
0.2
US
Quest Diagnostics Inc
NYSE:DGX
20.4
41%
0.5
US
R1 RCM Inc
NASDAQ:RCM
Negative Multiple: -275.9
4 308%
N/A
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
24.1
127%
0.2
US
DaVita Inc
NYSE:DVA
15.5
61%
0.3

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
109.3
2-Years Forward
P/E
97
3-Years Forward
P/E
75.5

See Also

Discover More